Zydus Lifesciences reports Q2 FY27 results with revenue growth but profit decline
1 report, 1 independent
Updated Wed 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Zydus Lifesciences reported revenue of Rs 7,910 crore for the July-September quarter of FY27, marking a 29 per cent increase year-on-year. Despite this growth, consolidated net profit declined 26.6 per cent to Rs 925.5 crore compared to the same period last year. The company's EBITDA margin also contracted to 23.95 per cent from 32.9 per cent in Q2 FY26.
From prokerala.com
Why it matters
The results show that while overall revenue increased, the decline in net profit and the contraction of the EBITDA margin indicate pressure on profitability. North America's formulations business contributed Rs 3,315 crore to revenue, which was up 21 per cent year-on-year.
From prokerala.com
Who's involved
- ApiCompany in Gifu, Japan